The purpose of this workshop was to discuss FDA’s proposal for a risk-based framework for addressing the regulatory oversight of a subset of in vitro diagnostic devices (IVDs) referred to as laboratory developed tests (LDTs), which are intended for clinical use and designed, manufactured and used within a single laboratory, and provide an additional opportunity for public comment. FDA’s detailed proposal is outlined in the draft guidance documents entitled “Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs)†and “FDA Notification and Medical Device Reporting for Laboratory Developed Tests (LDTs)†issued October 3, 2014.Â
The purpose of the workshop was to obtain feedback from all stakeholders on FDA’s proposal so that it can be refined in the best interest of public health.
- Date, Time and Location
- Federal Register Notice
- Webcast
- Transcripts
- Presentations
- Agenda
- Registration
- Contact Us
Date, Time and Location
This meeting will be held January 8-9, 2015, beginning at 8:30am at the following location:
Natcher Center at the NIH Campus
9000 Rockville Pike
Bldg. 45, Auditorium
Bethesda, MD 20814
The meeting will be webcast.